When was Galvanize founded?

Galvanize was founded in 2020 and raised its 1st funding round within a year of its incorporation.

Where is Galvanize located?

Galvanize is headquartered in San Carlos, United States. It is registered at Bridge Parkway 3200 CA 94065 Redwood CIty.

Who is the current CEO of Galvanize?

Jonathan Waldstreicher of Galvanize. They have also founded 1 company.

How many employees does Galvanize have?

As of Sep 30, 2026, the latest employee count at Galvanize is 170.

Is Galvanize a funded company?

Galvanize is a funded company, having raised a total of $210M across 4 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Oct 28, 2020.

When was the latest funding round of Galvanize?

Galvanize's latest funding was a $***** Series C round on Jul 07, 2025, with participation from 12 investors.

Where does Galvanize rank among its competitors?

Galvanize ranks 2nd amongst 28 active competitors, of which 15 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Pulsecare Medical Technology, which secured $14M in Nov, 2025.

Who are the top competitors of Galvanize?

Galvanize's top competitors include Kardium, Field Medical and Pulse Biosciences. Among them, Pulsecare Medical Technology secured the most recent funding round in November, 2025.

Galvanize - 2026 Company Profile, Team, Funding & Competitors

Galvanize is a series C company based in San Carlos (United States), founded in 2020 by Jonathan Waldstreicher. It operates as a Developer of pulsed electric field systems for various medical indications. Galvanize has raised $210M in funding from Fidelity Investments and Sofinnova Partners. The company has 28 active competitors, including 15 funded and 4 that have exited. Its top competitors include companies like Kardium, Field Medical and Pulse Biosciences.

Company Details

Developer of pulsed electric field systems for various medical indications. The company is developing and commercializing its energy platform for several indications, which include the RheOx system a minimally invasive bronchoscopic therapy for chronic bronchitis, The CENTAURI system for cardiac arrhythmias, and the Aliya system for immuno-oncology and soft tissue ablation.

Website: galvanizetx.com
Email ID: *****@galvanizetx.com
Phone Number: +1 **********
Registered Address: Bridge Parkway 3200 CA 94065 Redwood CIty

Key Metrics

Founded Year

2020

Location

San Carlos, United States

Stage

Series C

Total Funding

$210M in 4 rounds

Latest Funding Round

Series C, Jul 07, 2025, $*****

Investors

Fidelity Investments & 12 more

Ranked

2^nd among 28 active competitors

Employee Count

170 as on Sep 30, 2026

Similar Companies

Kardium & 26 more

View Galvanize's full profile

Galvanize is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Galvanize Therapeutics, Inc CIN: 0795.154.332 , Belgium, Active	Dec 21, 2022	-	-	-

Galvanize has raised a total funding of $210M over 4 rounds. Its first funding round was on Oct 28, 2020. Its latest funding round was a Series C round on Jul 07, 2025 for $*****. 12 investors participated in its latest round. Galvanize has 13 institutional investors.

Here is the list of recent funding rounds of Galvanize:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 07, 2025	1287109	Series C	5669742	7418324	8227498	1221335
Sep 15, 2022	4055916	Series B	8350010	8447715	3086693	Apple Tree Partners & 2 more
Mar 22, 2022	7493994	Series A	4738439	4106021	1684244	7392358

Access funding benchmarks and valuations. Sign up today!

View details of Galvanize's funding rounds and investors

The founders of Galvanize is Jonathan Waldstreicher. Jonathan Waldstreicher is the CEO of Galvanize.

Here are the details of Galvanize's key team members:

Jonathan Waldstreicher: Founder & CEO of Galvanize.

View details of Galvanize's Founder profiles and Board Members

Galvanize's employee count trend

Galvanize has 170 employees as of Sep 26. Here is Galvanize's employee count trend over the years:

Uncover Galvanize's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Galvanize include Kardium, Field Medical and Pulse Biosciences. Here is the list of Top 10 competitors of Galvanize, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Kardium 2007, Burnaby (Canada), Series C	Developer of ablation device for atrial fibrillation	$471M	Fidelity Investments, T. Rowe Price & 10 others	67/100
2nd	Galvanize 2020, San Carlos (United States), Series C	Developer of pulsed electric field systems for various medical indications	$210M	T. Rowe Price, Fidelity Investments & 11 others	59/100
3rd	Field Medical 2022, Encinitas (United States), Series B	Developer of device for the treatment of heart arrhythmia conditions	$89M	BioStar Capital, Cue Growth Partners	56/100
4th	Pulse Biosciences 2014, Burlingame (United States), Acquired	Developer of a platform technology called Nano-Pulse Electro-Signaling	$8M	MDB Capital, Sea Purity Investments & 1 others	51/100
5th	Farapulse 2014, Menlo Park (United States), Series C	Advanced cardiac ablation solutions for atrial fibrillation treatment	$36.3M	F-Prime Capital, Boston Scientific & 3 others	50/100
6th	Pulsecare Medical Technology 2021, Shenzhen (China), Series A	Developer of medical device solutions for heart and vascular care	$14M	Oriza Holdings, Loayal Valley Capital & 3 others	50/100
7th	Argá Medtech 2020, Epalinges (Switzerland), Series B	Developer of medical devices for treating cardiac arrhythmias	$58.5M	Advent Life Sciences, Earlybird & 2 others	49/100
8th	Affera 2014, Boston (United States), Acquired	Developer of devices to treat heart rhythm disorders	-	Innogest Capital, Bain Capital Life Sciences ... & 4 others	44/100
9th	AtriAN 2017, Galway (Ireland), Seed	Developing the device that targets to atrial fibrillation	$2.56M	Western Development Commission, Mayo Clinic Ventures ... & 4 others	40/100
10th	EnChannel Medical 2020, Ladera Ranch (United States), Series B	Developer of medical device for cardiac disorders	$110M	LAV, DragonBall Capital & 2 others	42/100